IRP
ABBV icon

Investment Research Partners’s AbbVie ABBV Stock Holding History

Investment Research Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
5,081
+273
+6% +$58.7K 0.43% 49
2026
Q1 		$1.05M Sell
4,808
-301
-6% -$66.8K 0.43% 51
2025
Q4 		$1.17M Buy
5,109
+258
+5% +$58.8K 0.5% 44
2025
Q3 		$1.09M Buy
+4,851
New +$988K 0.49% 45

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Investment Research Partners's ABBV Position: Q2 2026 in Review

Investment Research Partners increased its AbbVie (ABBV) stake by 5.7% in Q2 2026, buying an estimated $58.7K and bringing the position to 5,081 shares worth $1.28M. The position accounts for 0.43% of the portfolio, ranked #49.

Investment Research Partners first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Investment Research Partners held 5,081 shares of AbbVie worth $1.28M as of Q2 2026.
  • Investment Research Partners bought 273 AbbVie shares in Q2 2026, an estimated $58.7K.
  • AbbVie made up 0.43% of Investment Research Partners's portfolio in Q2 2026, its #49 holding.
  • Investment Research Partners first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Investment Research Partners's 13F filing for Q2 2026, filed 4 Aug 2026.